A patient with respiratory toxigenic diphtheria in Greece after more than 30 years

Epidemiol Infect. 2020 Oct 28:148:e274. doi: 10.1017/S0950268820002605.

Abstract

The introduction of treatment and systematic vaccination has significantly reduced diphtheria mortality; however, toxigenic strains continue to circulate worldwide. The emergence of an indigenous diphtheria case with fatal outcome in Greece, after 30 years, raised challenges for laboratory confirmation, clinical and public health management. Toxigenic Corynebacterium diphtheriae was isolated from an incompletely vaccinated 8-year-old boy with underlying conditions. The child passed away due to respiratory distress syndrome, before the administration of diphtheria antitoxin (DAT). All close contacts in family, school and hospital settings were investigated. Pharyngeal swabs were obtained to determine asymptomatic carriage. Chemoprophylaxis was given for 7 days to all close contacts and a booster dose to those incompletely vaccinated. Testing revealed a classmate, belonging to a subpopulation group (Roma), and incompletely vaccinated, as an asymptomatic carrier with an indistinguishable toxigenic strain (same novel multilocus sequence type, designated ST698). This case highlights the role of asymptomatic carriage, as the entry of toxigenic strains into susceptible populations can put individuals and their environment at risk. Maintenance of high-level epidemiological and microbiological surveillance, implementation of systematic vaccination in children and adults with primary and booster doses, availability of a DAT stockpile, and allowing timely administration are the cornerstone to prevent similar incidents in the future.

Keywords: DAT; Diphtheria; Greece; diphtheria vaccination; epidemiological surveillance.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Ampholyte Mixtures
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Bacterial
  • Child
  • Clarithromycin / administration & dosage
  • Clarithromycin / therapeutic use
  • Contact Tracing
  • Corynebacterium diphtheriae / isolation & purification
  • Diphtheria / epidemiology*
  • Diphtheria / pathology*
  • Diphtheria / prevention & control
  • Diphtheria-Tetanus-acellular Pertussis Vaccines / administration & dosage
  • Fatal Outcome
  • Greece / epidemiology
  • Humans
  • Male

Substances

  • Ampholyte Mixtures
  • Anti-Bacterial Agents
  • Antibodies, Bacterial
  • Diphtheria-Tetanus-acellular Pertussis Vaccines
  • Clarithromycin